CHENGDU, China, 7 de abril de 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" o la "Compañía") anunció hoy que la prestigiosa revista médica Nature Medicine ha publicado los resultados del ensayo de fase III de su anticuerpo anti-IL-4Rα, stapokibart, desarrollado...
Hence then, the article about nature medicine publica los datos del estudio de fase iii de stapokibart para la rinitis alergica estacional was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Nature Medicine publica los datos del estudio de fase III de Stapokibart para la rinitis alérgica estacional )
Also on site :
- Greg Evigan Shares Sweet ‘My Two Dads’ Throwback With Paul Reiser and Staci Keanan: ‘I Adore These 2 People!’
- JoAnna Garcia Swisher Breaks Her Silence After Shocking ‘Sweet Magnolias’ Cancellation: ‘How Do You Say Goodbye?’
- Carole King Wrote ‘Will You Love Me Tomorrow’ at 18 and It Became the First No. 1 Song by Any Girl Group; She Sang It 11 Years Later on Tapestry